Sepsis from tropical diseases Part III: Critical illness and Sepsis from Tuberculosis Disease
Summary
The term tuberculosis refers to infection with the strictly aerobic, slowly dividing, acid-fast staining bacterium Mycobacterium tuberculosis. Tuberculosis is an airborne-transmitted disease of poverty. When exposed to droplets containing Mycobacterium tuberculosis, 20-25% of individuals become infected, among whom 5-10% develop tuberculosis disease within a median time of 2 years. Over 2 billion people worldwide are infected with Mycobacterium tuberculosis but do not have symptoms. Ten percent of them develop tuberculosis disease during their lifetime under conditions such as stress, migration, poor nutrition, co-morbidities (e.g., HIV, diabetes mellitus, cancer, chronic obstructive pulmonary disease) or immunosuppressive therapy.
General Information
Enrolled trainees 90
Open 22.10.2023
Available for ESICM members
Student effort 1
Last Updated October 22, 2023
Intended Learning Outcomes
After studying this module on Sepsis from Tropical Diseases Part III: Critical Illness and Sepsis from Tuberculosis Disease you should be able to:
- List clinical symptoms of patients with critical illness or sepsis from tuberculosis disease.
- Discuss the diagnostic-work up of tuberculosis disease.
- Describe the intensive care management principles of patients with critical illness or sepsis from tuberculosis disease.
- Be aware of specific considerations of critical illness or sepsis from tuberculosis disease in chil-dren.
- Know about infection control measures for the management of patients with tuberculosis disease.
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology.
- 2.1 Obtains a history and performs an accurate clinical examination.
- 2.2 Undertakes timely and appropriate investigations.
- 2.5 Obtains appropriate microbiological samples and interprets results.
- 3.9 Recognises and manages the septic patient.
- 4.2 Manages antimicrobial drug therapy
- 11.2 Complies with local infection control measures.
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis from Tropical Diseases Part II: Sepsis from Severe Malaria
Summary
In this module, the pathophysiology, clinical symptoms, diagnostic work-up, and therapeutic management principles of patients suffering from sepsis from severe malaria are summarized.
General Information
Enrolled trainees 94
Open 22.10.2023
Available for ESICM members
Student effort 1
Last Updated October 22, 2023
Intended Learning Outcomes
After studying this module on Sepsis from Tropical Diseases Part II: Sepsis from Severe Malaria you should be able to:
- Understand the pathophysiology of severe malaria.
- List clinical symptoms of patients with sepsis from severe malaria.
- Discuss the diagnostic-work up of malaria.
- Describe the intensive care management principles of patients with sepsis from severe malaria.
- Be aware of specific considerations of severe malaria in children.
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology.
- 2.1 Obtains a history and performs an accurate clinical examination.
- 2.2 Undertakes timely and appropriate investigations.
- 2.5 Obtains appropriate microbiological samples and interprets results.
- 3.9 Recognises and manages the septic patient.
- 4.2 Manages antimicrobial drug therapy
- 11.2 Complies with local infection control measures.
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis from tropical diseases Part I: Sepsis from severe dengue and other viral Haemorrhagic fevers
Summary
Viral haemorrhagic fevers including Dengue Fever, Ebola/Marburg Virus Disease, Lassa Fever, Cri-mean-Congo Haemorrhagic Fever, Hanta and Yellow Fever, are a diverse group of potentially life-threatening zoonotic infections, many of which are graded as high consequence infectious diseases due to their exquisite contagiousness. Globally, Dengue Fever is the most common viral haemorrhagic fever and will, therefore, be discussed separately. With few exceptions (e.g., Crimean-Congo haemorrhagic fever), bleeding is a rather uncommon clinical symptom of viral haemorrhagic fevers. The majority of haemorrhagic fever viruses induce an inflammatory multisystem disease lead-ing to systemic endothelial dysfunction and capillary leakage.
General Information
Enrolled trainees 111
Open 22.10.2023
Available for ESICM members
Student effort 1
Last Updated October 22, 2023
Intended Learning Outcomes
After studying this module on Sepsis from Tropical Diseases Part I: Severe Dengue and other viral Haemorrhagic fevers you should be able to:
- List clinical symptoms of severe Dengue and other viral haemorrhagic fevers.
- Discuss the diagnostic-work up of severe Dengue and other viral haemorrhagic fevers.
- Describe the intensive care management principles of severe Dengue and other viral haemor-rhagic fevers.
- Be aware of specific considerations of these pathologies in children.
- Know about infection control measures for the management of patients with viral haemorrhagic fevers.
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology.
- 2.1 Obtains a history and performs an accurate clinical examination.
- 2.2 Undertakes timely and appropriate investigations.
- 2.5 Obtains appropriate microbiological samples and interprets results.
- 3.9 Recognises and manages the septic patient.
- 4.4 Uses fluids and vasoactive / inotropic drugs to support circulation.
- 11.2 Complies with local infection control measures.
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Immunocompromised patients Part IV
Part 4: Preventing Infection in the immunocompromised patient
Summary
Many patients in the Intensive Care Unit (ICU) are immunocompromised. In some, immunosuppression is easily apparent, especially when caused directly by underlying disease (such as hematological malignancies) or treatment (such as drugs to prevent organ rejection or as a side effect of cancer chemotherapy). In others, immunosuppression is less apparent and is induced by the underlying disease, for example following traumatic injury or sepsis, or as a response to therapies provided during intensive care (such as steroids).
Note: Infection remains an important cause of morbidity and mortality in immunocompromised patients.
While immunosuppression itself usually does not cause pathology, it does leave the patient more prone to infection. The clinician must maintain a high index of suspicion as there is currently no good test to measure the degree of immunosuppression. The consequences of immune suppression in the ICU highlight the importance of infection prevention and control, as well as surveillance measures to ensure that appropriate treatment is implemented safely and quickly. Intensive care clinicians require a thorough understanding of the mechanisms of immune suppression and the management of patients with immune dysfunction.
General Information
Enrolled trainees 1221
Open 23.08.2019
Available for ESICM members
Student effort 1
Last Updated April 19, 2024
Intended Learning Outcomes
After studying this module on Preventing Infection in Immunocompromised Patients you should be able to:
- Identify the most important and effective intervention for reducing infection in the ICU
- Discuss the pros and cons of infection prevention measures in the ICU, and how they can protect the immunocompromised patient
- Define the clinical situations where antimicrobial prophylaxis is warranted
Relevant competencies in CoBaTrICE
- 7.1 Identifies and attempts to minimise the physical and psychosocial consequences of critical illness for patients and families
- 11.2 Complies with local infection control measures
- 11.3 Identifies environmental hazards and promotes safety for patients & staff
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Immunocompromised patients Part III
Part 3: Managing the Immunocompromised Patient
Summary
The proportion of patients in the Intensive Care Unit (ICU) with deficient immune system has risen in recent years up to a third of all ICU admissions up to date. Contributing to this trend include advances in cancer treatment, increasing frequency of organ and hematopoietic cell transplantation, rise in anti-inflammatory and immune- modulating drugs. This leads to a larger number of patients with immune deficiencies that are at risk for severe infections.
Note: Infection remains an important cause of morbidity and mortality in immunocompromised patients.
The clinician must maintain a high index of suspicion as there is currently no good test to measure the degree of immunosuppression. The consequences of immune suppression in the ICU highlight the importance of infection prevention and control, as well as surveillance measures to ensure that appropriate treatment is implemented safely and quickly. Intensive care clinicians require a thorough understanding of the mechanisms of immune suppression and the management of patients with immune dysfunction.
General Information
Enrolled trainees 1302
Open 23.08.2019
Available for ESICM members
Student effort 2
Last Updated April 19, 2024
Intended Learning Outcomes
After studying this module on Managing the Immunocompromised Patient you should be able to:
- Define an approach to diagnosing and treating infection in a neutropenic patient
- Identify time periods of susceptibility and the different pathogens responsible for infection following solid organ transplant
- Identify time periods of susceptibility and the different pathogens responsible for infection following haematopoetic stem cell transplant
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 4.2 Manages antimicrobial drug therapy
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Immunocompromised patients Part II
Part 2: Mechanisms of Acquired Immunodeficiency
Summary
Note: Infection remains an important cause of morbidity and mortality in immunocompromised patients.
While immunosuppression itself does not cause pathology, it does leave the patient more prone to infection. The clinician must maintain a high index of suspicion as there is currently no good test to measure the degree of immunosuppression. The consequences of immune suppression in the ICU highlight the importance of infection prevention and control, as well as surveillance measures to ensure that appropriate treatment is implemented safely and quickly. Intensive care clinicians require a thorough understanding of the mechanisms of immune suppression and the management of patients with immune dysfunction.
General Information
Enrolled trainees 1351
Open 23.08.2019
Available for ESICM members
Student effort 1
Last Updated March 30, 2022
Intended Learning Outcomes
After studying this module on Mechanisms of Acquired Immunodeficiency you should be able to:
- Understand the elements of a normally functioning immune system
- List non-pharmacological and pharmacological mechanisms for acquired immunodeficiency
- Appreciate the potential for immunomodulatory therapies in the septic patient
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 2.10 Integrates clinical findings with laboratory investigations to form a differential diagnosis
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Immunocompromised patients Part I
Part 1: Recognizing the Immunocompromised Patient in the ICU
Summary
Note: Infection remains an important cause of morbidity and mortality in immunocompromised patients.
While immunosuppression itself does not cause pathology, it does leave the patient more prone to infection. The clinician must maintain a high index of suspicion as there is currently no good test to measure the degree of immunosuppression. The consequences of immune suppression in the ICU highlight the importance of infection prevention and control, as well as surveillance measures to ensure that appropriate treatment is implemented safely and quickly. Intensive care clinicians require a thorough understanding of the mechanisms of immune suppression and the management of patients with immune dysfunction.
General Information
Enrolled trainees 1628
Open 23.08.2019
Available for ESICM members
Student effort 1
Last Updated April 19, 2024
Intended Learning Outcomes
After studying this module on Recognizing the Immunocompromised Patient you should be able to:
- Define an approach to the identification of an immunocompromised patient
- Appreciate the utility (and limitations) of imaging, microbiological, and serologic testing for diagnosing infection in the immunocompromised patient
- Understand the promise, and present limitations, of new biochemical markers of infection and molecular diagnostic techniques for diagnosing infection in this patient population
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 2.10 Integrates clinical findings with laboratory investigations to form a differential diagnosis
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis and Septic Shock Part IV
Part 4: Adjuvant therapies in sepsis
Summary
Despite advances in our understanding of sepsis therapies, mortality rates remain about 40% in the presence of shock. In earlier courses the importance of prompt diagnosis, early resuscitation and directed therapies for sepsis have been emphasised. It is, however, important to appreciate that several other aspects of the disease and its treatment can also influence outcomes in sepsis. This section will highlight adjunctive interventions, based on available evidence, that may be considered part of a comprehensive therapeutic approach. Please note that only interventions with some evidence base, or those which have been directly discussed in recent Surviving Sepsis Campaign guidelines, will be discussed.
General Information
Enrolled trainees 1835
Open 24.05.2019
Available for ESICM members
Student effort 1
Last Updated July 4, 2022
Intended Learning Outcomes
After studying this module on Adjuvant Therapies for Sepsis you should be able to:
- Discuss the evidence, or lack thereof, supporting various adjuvant therapies in sepsis
- List the adjuvant sepsis therapies recommended by the latest Surviving Sepsis Campaign guidelines
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 3.1 Manages the care of the critically ill patient with specific acute medical conditions
- 3.9 Recognises and manages the septic patient
- 4.4 Uses fluids and vasoactive / inotropic drugs to support the circulation
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis and Septic Shock Part III
Part 3: Identification and Control of the Source of Infection
Summary
Sepsis is a life-threatening medical emergency, characterized by an organ dysfunction secondary to a deregulated inflammatory response caused by infection, as defined by Sepsis-3 criteria (Singer et al). It’s precise and timely diagnosis permits early initiation of therapy and is crucial for the patient’s survival and outcomes (Kumar et al.). Identification and proper control of the underlying source of infection is essential and can be challenging as clinical signs are often non-specific, and may, therefore, mimic other inflammatory, but non-infectious, conditions. An accurate patient assessment (i.e., a focused history, examination and targeted investigations) should be carried out in order to properly address the potentially vast differential diagnosis in this setting.
General Information
Enrolled trainees 1876
Open 24.05.2019
Available for ESICM members
Student effort 1
Last Updated July 4, 2022
Intended Learning Outcomes
After studying this module on Identification and control of the source of infection you should be able to:
- Describe a systematic approach to identifying the source of infection in a septic patient.
- Identify potential types of infection based upon the anatomic location.
- Describe the pros and cons of different methods (clinical, laboratory, imaging) to identify the source(s) of infection.
- Discuss the importance of timely source control on morbidity and mortality in sepsis.
- Identify the array of source control options available based upon the site of infection.
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 2.5 Obtains appropriate microbiological samples and interprets results
- 2.10 Integrates clinical findings with laboratory investigations to form a differential diagnosis
- 4.1 Prescribes drugs and therapies safely
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis and Septic Shock Part II
Part 2: Resuscitation and hemodynamic support of the patient with sepsis
Summary
Sepsis is a life-threatening condition caused by a dysregulated host response to infection that results in organ dysfunction. Septic shock refers to a subset of sepsis characterized by profound circulatory and cellular metabolism abnormalities and is associated with higher mortality rates than sepsis alone. In high-income countries, while 28-day mortality of sepsis episodes is about 25%, in septic shock it might rise up to 50%.
The septic shock definition has evolved over time, and although septic shock characterization was initially coupled to the need for vasopressor support, more recent definitions have highlighted the importance of metabolic abnormalities. To date, circulatory failure is defined as the evidence of inadequate tissue perfusion with impaired oxygen utilization by the cells, independently of the presence of arterial hypotension.
General Information
Enrolled trainees 2088
Open 24.05.2019
Available for ESICM members
Student effort 2
Last Updated April 25, 2024
Intended Learning Outcomes
After studying this module on Resuscitation and Hemodynamic Support of the Septic Patient you should be able to:
- Discuss a physiology-based approach to the endpoints of resuscitation of the septic patient
- Discuss a physiology-based approach to fluid resuscitation of the septic patient
- Describe vasopressor/inotropic agents used in the treatment of septic shock, and understand when they should be initiated
- List treatment options for the treatment of refractory septic shock
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.9 Monitors and responds to trends in physiological variables
- 3.3 Recognises and manages the patient with circulatory failure
- 3.9 Recognises and manages the septic patient
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis and Septic Shock Part I: Introduction, definitions and recognition of sepsis
Part 1: Introduction, definitions and recognition of sepsis
Summary
Sepsis is a life-threatening organ dysfunction characterized by a dysregulated host response to infection. Both sepsis and septic shock are major world-wide healthcare problems. Conservative estimates suggest that it can affect over 30 million people each year, accounting for billions in health care costs annually. Sepsis is a lethal process with mortality rates ranging from 10-50% and those who survive often suffer long-term physical, psychological and cognitive disability. Despite this, it is largely unknown to the lay public and until recent years, not recognized for the worldwide threat that it is.
General Information
Enrolled trainees 2533
Open 24.05.2019
Available for ESICM members
Student effort 1
Last Updated April 19, 2024
Intended Learning Outcomes
- Distinguish between the historic and most recent definitions of sepsis, and the criteria used to define them
- Describe the relative importance of scoring systems such as qSOFA and SOFA for the diagnosis of sepsis
- Discuss the utility and limitations of biomarkers and different microbiological techniques for the diagnosis of sepsis
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 1.4 Triages and prioritises patients appropriately, including timely admission to ICU
- 2.9 Monitors and responds to trends in physiological variables
- 2.10 Integrates clinical findings with laboratory investigations to form a differential diagnosis
- 3.9 Recognises and manages the septic patient
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.
Sepsis in the returning traveller
Summary
Globalisation and technological advancement have led to an increase in international. Approximately 8% of travellers to developing nations will require medical care during or after their travels. Travel medicine is unique, as certain geographical regions predispose travellers to specific travel-related illnesses. Sepsis in a returning traveller may be secondary to common pathogens; however, non-endemic infections unique and unfamiliar to most clinicians must also be considered.
In addition, antibiotic resistance has increased among the commonly encountered bacteria as a result of less rigorous regulation in the health care and agricultural industries in developing countries. Usual antibiotic protocols may not be adequate in dealing with these multidrug-resistant pathogens.
This chapter aims to introduce common travel-related illnesses that physicians may encounter in the intensiveintensive care unit (ICU) and the various employable diagnostic and management approaches.
General Information
Enrolled trainees 1351
Open 06.03.2018
Available for ESICM members
Last Updated March 6, 2018
Intended Learning Outcomes
After studying this module on Sepsis in the returning traveller, you should be able to:
- Outline an approach to fever in a returning traveller
- Describe the diagnosis and treat common vector-borne illnesses
- Describe various measures that can be implemented for the protection of health care workers and contact
Relevant competencies in CoBaTrICE
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.5 Obtains appropriate microbiological samples and interprets results
- 3.1 Manages the care of the critically ill patient with specific acute medical conditions
- 3.9 Recognises and manages the septic patient
- 4.2 Manages antimicrobial drug therapy
Enrollment Options
You are currently NOT enrolled in this course.
This course is available only for registered ESICM members.
If you are an ESICM member you can enrol yourself by clicking the Enrol Me button.
If there is no Enrol button on the top left of this card please check that you have login and that you are an ESICM Member.
Verify that you are logged in the Academy using your valid ESICM account to enrol yourself in the course.
Disclaimer
All authors of ACE courses sign a document declaring absence or any actual or potential conflicts of interest. In addition, they sign a copyright document confirming the work is their own and that they have obtained the necessary permission for any copyrighted material. The latter document also transfers the intellectual copyright to the ESICM. Both the conflict of interest and copyright forms are filed and stored in compliance with GDPR and are available for inspection upon request.